Ilovebenefits’s Blog

Just another WordPress.com weblog

Big Pharma Delays Release of Generic Drugs

Congress should use health reform to ban “pay-for-delay” deals
Lawmakers should include a provision in the health reform bill that would prevent brand-name drugmakers from entering into “pay-for-delay” deals with generic drug firms as a way to maintain the market exclusivity of their products, according to this Washington Post editorial. The practice forces government health insurance programs to pay billions of dollars for expensive treatments and consumers to lose an average of $3.5 billion annually in possible savings, the editorial adds. The Washington Post

Advertisements

January 16, 2010 - Posted by | drugs, healthcare | , , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: